Sirolimus vs tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?

Liver transplantation (LT) withstands as the most preferred therapeutic option for patients afflicted with hepatocellular carcinoma (HCC) and cirrhosis. To improve prognosis post-transplant, as well as to prevent the occurrence of rejection, a life-long immunosuppression strategy is implemented. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Faiza, Zakaria, Faiza, Enebong Nya, Godsgift, Mouchli, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453335/
https://www.ncbi.nlm.nih.gov/pubmed/36157369
http://dx.doi.org/10.4240/wjgs.v14.i8.862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453335/
https://www.ncbi.nlm.nih.gov/pubmed/36157369
http://dx.doi.org/10.4240/wjgs.v14.i8.862

Ejemplares similares